The #LIRADS Treatment Response Algorithm (TRA) helps radiologists to assess HCC treatment response after locoregional therapy using CT and MRI.
February 19, 2025 at 8:28 AM
Don’t miss this excellent update on the LIRADS 2024 Treatment Response Algorithm! Link valid for 1 week only!
vimeo.com/935851775/4b...
vimeo.com/935851775/4b...
January 10, 2025 at 5:10 PM
Don’t miss this excellent update on the LIRADS 2024 Treatment Response Algorithm! Link valid for 1 week only!
vimeo.com/935851775/4b...
vimeo.com/935851775/4b...
#LIRADS is now endorsed in the EASL clinical practice guidelines for the management of #HCC!
A major update for #LIRADS and radiology community!
www.journal-of-hepatology.eu/article/S016...
A major update for #LIRADS and radiology community!
www.journal-of-hepatology.eu/article/S016...
DEFINE_ME
www.journal-of-hepatology.eu
December 17, 2024 at 9:48 AM
#LIRADS is now endorsed in the EASL clinical practice guidelines for the management of #HCC!
A major update for #LIRADS and radiology community!
www.journal-of-hepatology.eu/article/S016...
A major update for #LIRADS and radiology community!
www.journal-of-hepatology.eu/article/S016...
How much do you worry about LIRADS-3 and LR-4 lesions in patients with cirrhosis?
HCC incidence rate 110/1000 person-year in patients with LR-3 lesions and 420/1000 for LR-4 lesions
🗝️ importance of close surveillance
Link: journals.lww.com/ajg/fulltext...
Podcast: webfiles.gi.org/podcasts/ajg...
HCC incidence rate 110/1000 person-year in patients with LR-3 lesions and 420/1000 for LR-4 lesions
🗝️ importance of close surveillance
Link: journals.lww.com/ajg/fulltext...
Podcast: webfiles.gi.org/podcasts/ajg...
November 12, 2024 at 3:03 AM
How much do you worry about LIRADS-3 and LR-4 lesions in patients with cirrhosis?
HCC incidence rate 110/1000 person-year in patients with LR-3 lesions and 420/1000 for LR-4 lesions
🗝️ importance of close surveillance
Link: journals.lww.com/ajg/fulltext...
Podcast: webfiles.gi.org/podcasts/ajg...
HCC incidence rate 110/1000 person-year in patients with LR-3 lesions and 420/1000 for LR-4 lesions
🗝️ importance of close surveillance
Link: journals.lww.com/ajg/fulltext...
Podcast: webfiles.gi.org/podcasts/ajg...
Congratulations to the Pediatric LIRADS workgroup for being awarded a Certificate of Merit for the #RSNA24 poster 🏅
The poster features @gschooler.bsky.social, Cara Morin, @towbinaj.bsky.social, and colleagues from other hospitals
The poster features @gschooler.bsky.social, Cara Morin, @towbinaj.bsky.social, and colleagues from other hospitals
December 3, 2024 at 8:10 PM
Congratulations to the Pediatric LIRADS workgroup for being awarded a Certificate of Merit for the #RSNA24 poster 🏅
The poster features @gschooler.bsky.social, Cara Morin, @towbinaj.bsky.social, and colleagues from other hospitals
The poster features @gschooler.bsky.social, Cara Morin, @towbinaj.bsky.social, and colleagues from other hospitals
A new study published in #InsightsIntoImaging developed a large language model (LLM) for #LIRADS v2018 categorization of hepatic observations based on free-text descriptions from MRI reports.
(1/2)
(1/2)
December 13, 2024 at 10:00 AM
A new study published in #InsightsIntoImaging developed a large language model (LLM) for #LIRADS v2018 categorization of hepatic observations based on free-text descriptions from MRI reports.
(1/2)
(1/2)
In this multicentric multinational observational study, involving 347 cirrhoritc patients with 540 LI-RADS 3 observations being followed up for 12 months, 28% of LI-RADS 3 observations progressed to LI-RADS 4 (14%) and LI-RADS 5 (14%).
A multicenter multinational retrospective study of the 1-year natural history of LI-RADS 3 observations in patients with cirrhosis - European Radiology
Objectives To assess the 1-year natural history of liver imaging reporting and data system (LI-RADS) 3 observations on contrast-enhanced MRI in cirrhotic patients across multiple international…
buff.ly
February 9, 2026 at 11:41 AM
🟡 What is the true meaning of LI-RADS 3?
According to the liver imaging reporting and data system (LI-RADS), LI-RADS 3 observations are considered indeterminate, stating a 15 – 25% risk of progression to LI-RADS 5 (i.e. definitely HCC).
According to the liver imaging reporting and data system (LI-RADS), LI-RADS 3 observations are considered indeterminate, stating a 15 – 25% risk of progression to LI-RADS 5 (i.e. definitely HCC).
February 3, 2026 at 6:09 AM
June 11, 2026 at 9:05 AM
May 15, 2025 at 7:11 AM
ESGAR Rising Star Roberto Cannella speaking about HCC LIRADS in the Auditorium now!
@cannellaroberto.bsky.social
#esgar #esgar2025 #radiology #abdominalradiology #abdorad
@cannellaroberto.bsky.social
#esgar #esgar2025 #radiology #abdominalradiology #abdorad
May 15, 2025 at 7:31 AM
ESGAR Rising Star Roberto Cannella speaking about HCC LIRADS in the Auditorium now!
@cannellaroberto.bsky.social
#esgar #esgar2025 #radiology #abdominalradiology #abdorad
@cannellaroberto.bsky.social
#esgar #esgar2025 #radiology #abdominalradiology #abdorad
The #LIRADS Treatment Response Algorithm (TRA) helps radiologists to assess HCC treatment response after locoregional therapy using CT and MRI.
February 12, 2025 at 11:02 AM
The #LIRADS Treatment Response Algorithm (TRA) helps radiologists to assess HCC treatment response after locoregional therapy using CT and MRI.
🤔What's your take on these findings?
💭Does LI-RADS have the potential to simplify and standardize HCC diagnostics globally?
🔗 Full study: doi.org/10.1177/0846...
@bodyradguy.bsky.social @duotango.bsky.social @societyabdrad.bsky.social
#Radiology #HCC #LiverDisease #MedEd #PatientCare
💭Does LI-RADS have the potential to simplify and standardize HCC diagnostics globally?
🔗 Full study: doi.org/10.1177/0846...
@bodyradguy.bsky.social @duotango.bsky.social @societyabdrad.bsky.social
#Radiology #HCC #LiverDisease #MedEd #PatientCare
Do Risk Factors for HCC Impact the Association of CT/MRI LIRADS Major Features With HCC? An Individual Participant Data Meta-Analysis - Robert G. Adamo, Eric Lam, Jean-Paul Salameh, Christian B. van d...
Background: Guidelines suggest the Liver Imaging Reporting and Data System (LI-RADS) may not be applicable for some populations at risk for hepatocellular carci...
doi.org
January 7, 2025 at 4:15 PM
🤔What's your take on these findings?
💭Does LI-RADS have the potential to simplify and standardize HCC diagnostics globally?
🔗 Full study: doi.org/10.1177/0846...
@bodyradguy.bsky.social @duotango.bsky.social @societyabdrad.bsky.social
#Radiology #HCC #LiverDisease #MedEd #PatientCare
💭Does LI-RADS have the potential to simplify and standardize HCC diagnostics globally?
🔗 Full study: doi.org/10.1177/0846...
@bodyradguy.bsky.social @duotango.bsky.social @societyabdrad.bsky.social
#Radiology #HCC #LiverDisease #MedEd #PatientCare
🚨 How reliable is CT/MRI LI-RADS for diagnosing HCC in global populations?
New meta-analysis of 2,958 patients reveals:
⭐88% sensitivity & 82% specificity for HCC detection
⭐Consistency across key risk factors like cirrhosis & chronic HBV
🔗 Full study: doi.org/10.1177/0846...
#HCC #LIRADS #CTMRI
New meta-analysis of 2,958 patients reveals:
⭐88% sensitivity & 82% specificity for HCC detection
⭐Consistency across key risk factors like cirrhosis & chronic HBV
🔗 Full study: doi.org/10.1177/0846...
#HCC #LIRADS #CTMRI
Do Risk Factors for HCC Impact the Association of CT/MRI LIRADS Major Features With HCC? An Individual Participant Data Meta-Analysis - Robert G. Adamo, Eric Lam, Jean-Paul Salameh, Christian B. van d...
Background: Guidelines suggest the Liver Imaging Reporting and Data System (LI-RADS) may not be applicable for some populations at risk for hepatocellular carci...
doi.org
January 7, 2025 at 4:15 PM
🚨 How reliable is CT/MRI LI-RADS for diagnosing HCC in global populations?
New meta-analysis of 2,958 patients reveals:
⭐88% sensitivity & 82% specificity for HCC detection
⭐Consistency across key risk factors like cirrhosis & chronic HBV
🔗 Full study: doi.org/10.1177/0846...
#HCC #LIRADS #CTMRI
New meta-analysis of 2,958 patients reveals:
⭐88% sensitivity & 82% specificity for HCC detection
⭐Consistency across key risk factors like cirrhosis & chronic HBV
🔗 Full study: doi.org/10.1177/0846...
#HCC #LIRADS #CTMRI
Independent predictors of progression included lesion size (≥9.5 mm), Child-Pugh class C and alcohol-related liver disease.
#LIRADS #HepatocellularCarcinoma #PrecisionMedicine
#LIRADS #HepatocellularCarcinoma #PrecisionMedicine
A multicenter multinational retrospective study of the 1-year natural history of LI-RADS 3 observations in patients with cirrhosis - European Radiology
Objectives To assess the 1-year natural history of liver imaging reporting and data system (LI-RADS) 3 observations on contrast-enhanced MRI in cirrhotic patients across multiple international…
buff.ly
January 30, 2026 at 8:01 AM
Independent predictors of progression included lesion size (≥9.5 mm), Child-Pugh class C and alcohol-related liver disease.
#LIRADS #HepatocellularCarcinoma #PrecisionMedicine
#LIRADS #HepatocellularCarcinoma #PrecisionMedicine
We're excited to introduce the Radiology Calculators mobile app 📱🩻
30+ calculators in one place: from ACR RADS (#ORADS, #LIRADS, #PIRADS, #TIRADS) to #AAST trauma scoring, volume calculations, and more
🚀 Available on iOS & Android: radathand.com/apps/radcalc...
#Radiology #RadTwitter #MedTwitter
30+ calculators in one place: from ACR RADS (#ORADS, #LIRADS, #PIRADS, #TIRADS) to #AAST trauma scoring, volume calculations, and more
🚀 Available on iOS & Android: radathand.com/apps/radcalc...
#Radiology #RadTwitter #MedTwitter
January 29, 2026 at 4:06 PM
We're excited to introduce the Radiology Calculators mobile app 📱🩻
30+ calculators in one place: from ACR RADS (#ORADS, #LIRADS, #PIRADS, #TIRADS) to #AAST trauma scoring, volume calculations, and more
🚀 Available on iOS & Android: radathand.com/apps/radcalc...
#Radiology #RadTwitter #MedTwitter
30+ calculators in one place: from ACR RADS (#ORADS, #LIRADS, #PIRADS, #TIRADS) to #AAST trauma scoring, volume calculations, and more
🚀 Available on iOS & Android: radathand.com/apps/radcalc...
#Radiology #RadTwitter #MedTwitter
#RANZCR2025
9C session Liver GB -some pearls
Shabnam Grover (Shadra uni)
-> US GB-RADS5 - direct liver invasion
Karthik Ganesan (Reliance Life Sciences)
-> radio-pathological-genomics correlation for intrahep #CholangioCa
-> Hepatocarcinogenesis in LIRADS-M, etc
#PointOfCare #p53 #kras #Cancer
9C session Liver GB -some pearls
Shabnam Grover (Shadra uni)
-> US GB-RADS5 - direct liver invasion
Karthik Ganesan (Reliance Life Sciences)
-> radio-pathological-genomics correlation for intrahep #CholangioCa
-> Hepatocarcinogenesis in LIRADS-M, etc
#PointOfCare #p53 #kras #Cancer
October 26, 2025 at 8:42 PM
#RANZCR2025
9C session Liver GB -some pearls
Shabnam Grover (Shadra uni)
-> US GB-RADS5 - direct liver invasion
Karthik Ganesan (Reliance Life Sciences)
-> radio-pathological-genomics correlation for intrahep #CholangioCa
-> Hepatocarcinogenesis in LIRADS-M, etc
#PointOfCare #p53 #kras #Cancer
9C session Liver GB -some pearls
Shabnam Grover (Shadra uni)
-> US GB-RADS5 - direct liver invasion
Karthik Ganesan (Reliance Life Sciences)
-> radio-pathological-genomics correlation for intrahep #CholangioCa
-> Hepatocarcinogenesis in LIRADS-M, etc
#PointOfCare #p53 #kras #Cancer
#RANZCR2025
9C liver pancreas session
Enjoyed chairing the session & learning from a stellar speakers providing insights into intra-/ extra cholangioCa, US GB-RADS, LIRADS-M, -TRV
Drs Sudhakar Venkatesh (Mayo),
Karthik Ganesan (Reliance Life Sciences),
Shabnam Grover (Sharda University)
9C liver pancreas session
Enjoyed chairing the session & learning from a stellar speakers providing insights into intra-/ extra cholangioCa, US GB-RADS, LIRADS-M, -TRV
Drs Sudhakar Venkatesh (Mayo),
Karthik Ganesan (Reliance Life Sciences),
Shabnam Grover (Sharda University)
October 25, 2025 at 12:40 PM
#RANZCR2025
9C liver pancreas session
Enjoyed chairing the session & learning from a stellar speakers providing insights into intra-/ extra cholangioCa, US GB-RADS, LIRADS-M, -TRV
Drs Sudhakar Venkatesh (Mayo),
Karthik Ganesan (Reliance Life Sciences),
Shabnam Grover (Sharda University)
9C liver pancreas session
Enjoyed chairing the session & learning from a stellar speakers providing insights into intra-/ extra cholangioCa, US GB-RADS, LIRADS-M, -TRV
Drs Sudhakar Venkatesh (Mayo),
Karthik Ganesan (Reliance Life Sciences),
Shabnam Grover (Sharda University)
Dr. Jans Ricke just shared that new LIRADS guidelines will be released soon, featuring a revised diagnostic protocol for early #HCC detection 👀 #ESMOGI26
#MedSky #MedEd #LiverCancer
#MedSky #MedEd #LiverCancer
July 1, 2026 at 6:03 PM
Dr. Jans Ricke just shared that new LIRADS guidelines will be released soon, featuring a revised diagnostic protocol for early #HCC detection 👀 #ESMOGI26
#MedSky #MedEd #LiverCancer
#MedSky #MedEd #LiverCancer